Increasing prevalence of
narcolepsy, growing the obese population,
increasing demands for effective treatment, rising research and development are
estimated to be some of the significant drivers for the global narcolepsy
market.
Narcolepsy
Market is expected to register a CAGR of
9.7 % with USD 6.9 Billion by 2030
Various factors are adding to the global narcolepsy market
share. These factors, as per the new MRFR report, include favorable
reimbursement policies, increase in healthcare expenditure, increase in
research and development activities for finding a cure for narcolepsy,
extensive efforts undertaken by non-government and government organizations to
spread awareness about narcolepsy, and growing demand for advanced therapies
for sleeping disorders. Additional factors adding market growth include an
increase in stress levels, rising cases of narcolepsy for an unhealthy
lifestyle, and increasing awareness about sleep disorders.
On the contrary, low per capita healthcare expenditure in middle
& low-income countries and lack of awareness are factors that may impede
the global narcolepsy market growth over the forecast period.
Major Key
Players:
Some of the Narcolepsy Market Players are Jazz Pharmaceuticals plc
(Republic of Ireland), BIOPROJET (Paris), Arena Pharmaceuticals, Inc. (U.S.),
Graymark Healthcare, Inc. (U.S.), Mylan N.V. (U.S., Teva Pharmaceutical
Industries Ltd. (Israel), Novartis AG (Switzerland), Shire (Republic of Ireland),
Shionogi Inc. (U.S.), Ligand Pharmaceuticals, Inc. (U.S.), and others.
Segment Analysis
The MRFR report provides an inclusive segmental
analysis of the global narcolepsy market based on end user, treatment, type,
and diagnosis.
By type, the global narcolepsy market is segmented
into type 2 narcolepsy, type 1 narcolepsy, and others.
By diagnosis, the global narcolepsy market is
segmented into multiple sleep latency test, polysomnogram, and others.
By treatment, the global narcolepsy market is
segmented into sodium oxybate, antidepressants, stimulants, and others. The
stimulants segment is again segmented into armodafinil, modafinil, and others.
The antidepressants segment is again segmented into noradrenergic reuptake
inhibitors, selective serotonin, tricyclics, and others. The tricyclics segment
is again segmented into clomipramine, desipramine, imipramine, and others. The
selective serotonin & noradrenergic segment is again segmented into
fluoxetine, venlafaxine, and others.
By end users, the global narcolepsy market is
segmented into retail pharmacies, clinics, hospitals, and others.
Regional Analysis
Based on the region, the global
narcolepsy market covers the recent trends and growth opportunities across
Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa
(MEA). Of these, the Americas will have the lions share in the market over the
forecast period for a huge patient population, high healthcare expenditure, the
presence of key industry players, and a well-developed healthcare sector.
Canada and the US are the chief contributors in the region.
The global narcolepsy market in
Europe is predicted to have the second-largest share over the forecast period
for the presence of developed economies such as Germany, Italy, and France,
increasing cases of obesity, huge patient population, and availability of funds
for research and development.
The global narcolepsy market in
the APAC region is predicted to grow at a quick pace over the forecast period
for favorable government policies, developing healthcare sector, and the
presence of developing economies such as China & India.
The global narcolepsy market in
the MEA is predicted to have the smallest share in the market over the forecast
period for stringent government policies in the African region and weak
economies. The market in the Middle East will have a favorable growth for the
huge healthcare expenditure due to the presence of several developed economies
such as Qatar, Kuwait, and Saudi Arabia.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
